Cronos Group Inc. Stock: price and management transactions · United States · SEC (Form 4)Follow the Cronos Group Inc. share price and the full management transaction log of the company, a listed issuer based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Operating in the Food & Agriculture sector, Cronos Group Inc. has published 147 public disclosures. Market capitalisation: €1.1bn. The latest transaction was reported on 7 August 2026 (50 - Grant of options). Among the most active insiders: ADLER JASON MARC. Every trade is free.
Fundamental score
Ranked 20,357 of 29,062 companies
FCF yld -0.0%
Earn yld -0.8%
EV/EBITDA ·
ROE 7.0%
Gross mgn 43%
Net mgn -6.4%
Debt/EBITDA ·
Pillars 2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 7 August 2026
All Executives147 Thresholds0 Prospectus0 Other0
Declarations 147 total
◇ 4 - Director of Issuer · Executives · 6 Aug 2026
2 shares Units Deferred Share Units [cash settled] TSXSEDI:4761508 ◇ 4 - Director of Issuer · Executives · 6 Aug 2026
48,860 shares Units Deferred Share Units [cash settled] TSXSEDI:4761506 ◇ 4 - Director of Issuer · Executives · 6 Aug 2026
1 shares Units Deferred Share Units [cash settled] TSXSEDI:4761501 ◇ 4 - Director of Issuer · Executives · 6 Aug 2026
48,860 shares Units Deferred Share Units [cash settled] TSXSEDI:4761499 ◇ 4 - Director of Issuer · Executives · 6 Aug 2026
48,860 shares Units Deferred Share Units [cash settled] TSXSEDI:4761495 ◇ See Remarks · Executives · 12 May 2026
20,622 shares 0COMMON SHARES SEC:0001830967-26-000009:0
◇ See Remarks · Executives · 12 May 2026
10,597 shares 0COMMON SHARES SEC:0001923055-26-000008:0
◇ See remarks · Executives · 12 May 2026
10,367 shares 0COMMON SHARES SEC:0002018799-26-000007:0
◇ See Remarks · Executives · 12 May 2026
9,412 shares 0COMMON SHARES SEC:0002103831-26-000004:0
◇ See Remarks · Executives · 19 Mar 2026
28,429 shares 0COMMON SHARES SEC:0001804953-26-000009:0
◇ See Remarks · Executives · 15 Mar 2026
24,236 shares 0COMMON SHARES SEC:0001937121-26-000006:0
◇ See Remarks · Executives · 15 Mar 2026
23,897 shares 0COMMON SHARES SEC:0001923055-26-000006:0
◇ See Remarks · Executives · 15 Mar 2026
20,938 shares 0COMMON SHARES SEC:0001830967-26-000007:0
◇ See Remarks · Executives · 15 Mar 2026
45,226 shares 0COMMON SHARES SEC:0001804953-26-000007:0
◇ See remarks below · Executives · 15 Mar 2026
324,540 shares 0COMMON SHARES SEC:0001797199-26-000006:0
◇ Chief Growth Officer · Executives · 15 Mar 2026
59,191 shares 0COMMON SHARES SEC:0001796124-26-000007:0
◇ See remarks · Executives · 12 Mar 2026
15,715 shares 0COMMON SHARES SEC:0002018799-26-000004:0
◇ See Remarks · Executives · 12 Mar 2026
26,825 shares 0COMMON SHARES SEC:0001937121-26-000004:0
◇ See Remarks · Executives · 12 Mar 2026
23,809 shares 0COMMON SHARES SEC:0001923055-26-000004:0
◇ See Remarks · Executives · 12 Mar 2026
21,930 shares 0COMMON SHARES SEC:0001830967-26-000005:0
◇ See Remarks · Executives · 12 Mar 2026
47,368 shares 0COMMON SHARES SEC:0001804953-26-000005:0
◇ See remarks below · Executives · 12 Mar 2026
339,879 shares 0COMMON SHARES SEC:0001797199-26-000004:0
◇ Chief Growth Officer · Executives · 12 Mar 2026
65,179 shares 0COMMON SHARES SEC:0001796124-26-000005:0
◇ See Remarks · Executives · 8 Mar 2026
21,484 shares 0COMMON SHARES SEC:0001937121-26-000002:0
◇ See Remarks · Executives · 8 Mar 2026
24,434 shares 0COMMON SHARES SEC:0001923055-26-000002:0
25 of 147 declarations
Load more (122 remaining) 关于 Cronos Group Inc. Cronos Group Inc. 是一家专业的大麻和大麻素公司,在美国纳斯达克上市,股票代码为 CRON,其运营根基在加拿大,并在国际市场(包括美国,作为一家在美国上市的发行商和全球分销足迹)拥有商业敞口。从股票分析师的角度来看,Cronos 最好被理解为一个品牌消费健康和大麻平台,而不是一个商品种植商。该公司成立于 2012 年,此后建立了一个以品牌产品开发、遗传学以及针对成人和医疗消费者的差异化配方为中心的商业模式。其总部位于多伦多,这反映了该公司的加拿大起源及其运营基地的核心。Cronos 的战略是通过知识产权、消费品牌和产品创新进行竞争,在这些领域,规模并非成功的唯一决定因素。其主要品牌组合包括 Spinach®、PEACE NATURALS® 和 Lord Jones®,其他品牌延伸出现在特定类别和市场中。该公司的主要产品线包括干花、预卷、电子烟弹和一体式电子烟、软糖、其他食用产品和医用大麻形式。这种组合使 Cronos 能够接触到增长更快且可能利润更高的类别,同时还为成人和医疗渠道提供了多样化的市场途径。在竞争方面,Cronos 并非北美最大的大麻运营商之一,但由于品牌知名度、类别创新和重要的国际医疗足迹,它仍然具有相关性。公司最近的沟通表明,Spinach 在加拿大继续保持强势地位,尤其是在电子烟、软糖和预卷创新方面,而 PEACE NATURALS 一直在推动以色列医用大麻市场的领导地位。2026 年初,Cronos 还强调了在加拿大推出新的 Spinach 预卷产品并持续国际增长,Lord Jones 扩展到以色列的医疗市场并获得关注。该公司还强调了运营纪律和现金流改善,表明其增长态势比行业早期资本密集型扩张阶段更具选择性。对于法国、比利时和瑞士的投资者而言,Cronos 提供了一个专注的大麻股票故事:品牌产品创新、医疗市场选择性和国际多元化,但伴随着与监管、价格压力和执行波动相关的常见行业风险。